1h Free Analyst Time
The quinidine sulfate market is forecasted to grow by USD 272.6 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the quinidine sulfate market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing incidence of malaria, robust pipeline and drug approvals, and increasing mergers and acquisitions by market vendors.
The quinidine sulfate market is segmented as below:
By Disease Type
- Malaria
- Arrhythmias
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the quinidine sulfate market covers the following areas:
- Quinidine Sulfate Market sizing
- Quinidine Sulfate Market forecast
- Quinidine Sulfate Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global quinidine sulfate market: Bennet Pharmaceuticals Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Buchler GmbH, Cipla Inc., Inga Laboratories P. Ltd., Ipca Laboratories, Koninklijke DSM NV, Lark Laboratories India Ltd., Merck and Co. Inc., PMC Group Inc., PRISM INDUSTRIES PVT. LTD., PT Bio Farma, PT Sinkona Indonesia lestar, Teva Pharmaceutical Industries Ltd., Vital Laboratories Pvt. Ltd., and VIVAN Life Sciences Pvt. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strong funding for eradication of malaria."
According to the report, one of the major drivers for this market is the growing incidence of malaria.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bennet Pharmaceuticals Ltd.
- Biophore India Pharmaceuticals Pvt. Ltd.
- Buchler GmbH
- Cipla Inc.
- Inga Laboratories P. Ltd.
- Ipca Laboratories
- Koninklijke DSM NV
- Lark Laboratories India Ltd.
- Merck and Co. Inc.
- PMC Group Inc.
- PRISM INDUSTRIES PVT. LTD.
- PT Bio Farma
- PT Sinkona Indonesia lestar
- Teva Pharmaceutical Industries Ltd.
- Vital Laboratories Pvt. Ltd.
- VIVAN Life Sciences Pvt. Ltd.
